All addictions are classified as “Reward Deficiency Syndrome” (RDS)
Following extensive research by many world class scientists, a new understanding of addictive behaviors arose suggesting that alcoholism is similar to opiate, cocaine, nicotine, food addiction, and even certain repetitive behaviors (e.g. gambling, sex addiction, etc.), in terms of how these substances work in the brain to release dopamine. This expansion of the addiction definition is based on an understanding that both psychoactive drugs and certain behaviors that produce a surge of dopamine in the mid-brain are the biological substrate for addictive behavior. Individuals who are genetically predisposed to addiction are at higher risk for this “Reward Deficiency Syndrome” due to the interplay of genetic and environmental factors.
In essence, high risk individuals seek substances including alcohol, opiates, cocaine, nicotine, and/or glucose. These are all substances known to cause preferential release of dopamine at the NAc to activate dopaminergic pathways in order to offset their low D2 receptors, caused by at least one gene variant the dopamine D2 receptor gene Taq1 A1 allele antecedents. These behaviors include not only addictive but impulsive, compulsive and even personality.
The new definition of addiction
As newly defined by the American Society of Addiction Medicine (ASAM 2011), the United States’ Addiction Specialty Society of Physicians, addiction is a primary, chronic disease involving brain reward, motivation, memory and related circuitry. Dysfunction in these circuits leads to characteristic biological, psychological, social and spiritual manifestations. This is reflected in persons compulsively pursuing reward and/or relief by substance use and other behaviors. Addiction cannot be cured but can be brought into remission through a program of treatment, abstinence from all psychoactive substances, and supported recovery. Alcohol and other drugs have long been recognized as addictive substances and addiction is now generally recognized as a chronic disease of the brain that involves relapse, progressive development, and the potential for fatality if not treated. Impairment of the reward circuitry must be addressed to prevent relapse, support recovery, and enhance the quality of life.
The key is to naturally boost dopamine function at the reward site of the brain
While scientists in the pharmaceutical industry found ways to increase dopamine function in the reward site of the brain with very powerful drugs known as dopamine agonists, long-term administration results in a reduction instead of a boost of brain dopamine function lead to an “Unhappy Brain.”
However, following decades of research and 41 clinical trials, a novel natural complex known as restoreGen® (research code KB220Z and KB220PAM) has finally come to market especially for the millions of family members afflicted with RDS. The list of benefits is quite remarkable and includes:
- positive recovery rates
- prevention of addiction relapse
- reduction of Against Medical Advice (AMA) rates
- direct dopaminergic activation at the reward site of the brain
- regulation of brain wave activity in the cingulate gyrus (relapse site of the brain) increasing alpha and increasing low beta bands
- reduction of aberrant craving behavior
- increased energy
- enhanced focus and attention
- most importantly enhanced feelings of well-being and happiness